HEADER SIGNALING PROTEIN 09-DEC-14 4UDA TITLE MR IN COMPLEX WITH DEXAMETHASONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: MINERALOCORTICOID RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN, RESIDUES 735-984; COMPND 5 SYNONYM: MR, NUCLEAR RECEPTOR SUBFAMILY 3 GROUP C MEMBER 2; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 1; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: RESIDUES 1427-1441; COMPND 12 SYNONYM: NCOA-1, CLASS E BASIC HELIX-LOOP-HELIX PROTEIN 74, BHLHE74, COMPND 13 PROTEIN HIN-2, RIP160, RENAL CARCINOMA ANTIGEN NY-REN-52, STEROID COMPND 14 RECEPTOR COACTIVATOR 1, SRC-1, NCOA1 PEPTIDE; COMPND 15 EC: 2.3.1.48; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET24A; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_VECTOR: PET24A KEYWDS SIGNALING PROTEIN, NUCLEAR HORMONE RECEPTOR, LIGAND COMPLEX, PEPTIDE KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR K.EDMAN,A.HOGNER,A.HUSSEIN,M.BJURSELL,A.AAGAARD,S.BACKSTROM,C.BODIN, AUTHOR 2 L.WISSLER,T.JELLESMARK-JENSEN,A.CAVALLIN,U.KARLSSON,E.NILSSON, AUTHOR 3 D.LECINA,R.TAKAHASHI,C.GREBNER,M.LEPISTO,V.GUALLAR REVDAT 5 20-DEC-23 4UDA 1 REMARK REVDAT 4 04-APR-18 4UDA 1 REMARK REVDAT 3 16-DEC-15 4UDA 1 JRNL REVDAT 2 09-DEC-15 4UDA 1 JRNL REVDAT 1 25-NOV-15 4UDA 0 JRNL AUTH K.EDMAN,A.HOSSEINI,M.K.BJURSELL,A.AAGAARD,L.WISSLER, JRNL AUTH 2 A.GUNNARSSON,T.KAMINSKI,C.KOHLER,S.BACKSTROM,T.J.JENSEN, JRNL AUTH 3 A.CAVALLIN,U.KARLSSON,E.NILSSON,D.LECINA,R.TAKAHASHI, JRNL AUTH 4 C.GREBNER,S.GESCHWINDNER,M.LEPISTO,A.C.HOGNER,V.GUALLAR JRNL TITL LIGAND BINDING MECHANISM IN STEROID RECEPTORS: FROM JRNL TITL 2 CONSERVED PLASTICITY TO DIFFERENTIAL EVOLUTIONARY JRNL TITL 3 CONSTRAINTS. JRNL REF STRUCTURE V. 23 2280 2015 JRNL REFN ISSN 0969-2126 JRNL PMID 26602186 JRNL DOI 10.1016/J.STR.2015.09.012 REMARK 2 REMARK 2 RESOLUTION. 2.03 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.03 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.70 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 83.7 REMARK 3 NUMBER OF REFLECTIONS : 15085 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 762 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.03 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.17 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 83.73 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 1808 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2125 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1721 REMARK 3 BIN R VALUE (WORKING SET) : 0.2098 REMARK 3 BIN FREE R VALUE : 0.2660 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.81 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 87 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2069 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 101 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.44 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.86 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.77100 REMARK 3 B22 (A**2) : 9.48430 REMARK 3 B33 (A**2) : -3.71340 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.238 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.248 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.199 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.237 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.198 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.931 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.869 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2163 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2929 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 763 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 54 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 299 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2163 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 277 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2643 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.01 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.48 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.64 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: IDEAL-DIST CONTACT TERM CONTACT SETUP. REMARK 3 ALL ATOMS HAVE CCP4 ATOM TYPE FROM LIBRARY REMARK 4 REMARK 4 4UDA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 09-DEC-14. REMARK 100 THE DEPOSITION ID IS D_1290062139. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-NOV-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : RIGAKU R-AXIS HTC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15085 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.030 REMARK 200 RESOLUTION RANGE LOW (A) : 40.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 83.9 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.03 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.08 REMARK 200 COMPLETENESS FOR SHELL (%) : 83.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.50 REMARK 200 R MERGE FOR SHELL (I) : 0.50000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2AA2 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG4000, 0.1M NACL, 0.2M PIPES PH REMARK 280 7.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.50000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 22.61500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.70000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 22.61500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.50000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.70000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1320 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11790 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.8 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 734 REMARK 465 THR A 735 REMARK 465 PRO A 736 REMARK 465 SER A 737 REMARK 465 SER A 910 REMARK 465 PRO A 911 REMARK 465 ASN A 912 REMARK 465 ASN A 913 REMARK 465 LYS A 984 REMARK 465 PRO B 1427 REMARK 465 GLN B 1428 REMARK 465 ALA B 1429 REMARK 465 GLN B 1430 REMARK 465 GLN B 1431 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 888 69.80 -110.24 REMARK 500 HIS A 982 -169.99 -122.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1984 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DEX A 1985 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4UDB RELATED DB: PDB REMARK 900 MR IN COMPLEX WITH DESISOBUTYRYLCICLESONIDE REMARK 900 RELATED ID: 4UDC RELATED DB: PDB REMARK 900 GR IN COMPLEX WITH DEXAMETHASONE REMARK 900 RELATED ID: 4UDD RELATED DB: PDB REMARK 900 GR IN COMPLEX WITH DESISOBUTYRYLCICLESONIDE DBREF 4UDA A 735 984 UNP P08235 MCR_HUMAN 735 984 DBREF 4UDA B 1427 1441 UNP Q15788 NCOA1_HUMAN 1427 1441 SEQADV 4UDA GLY A 734 UNP P08235 EXPRESSION TAG SEQADV 4UDA SER A 808 UNP P08235 CYS 808 ENGINEERED MUTATION SEQADV 4UDA SER A 910 UNP P08235 CYS 910 ENGINEERED MUTATION SEQRES 1 A 251 GLY THR PRO SER PRO VAL MET VAL LEU GLU ASN ILE GLU SEQRES 2 A 251 PRO GLU ILE VAL TYR ALA GLY TYR ASP SER SER LYS PRO SEQRES 3 A 251 ASP THR ALA GLU ASN LEU LEU SER THR LEU ASN ARG LEU SEQRES 4 A 251 ALA GLY LYS GLN MET ILE GLN VAL VAL LYS TRP ALA LYS SEQRES 5 A 251 VAL LEU PRO GLY PHE LYS ASN LEU PRO LEU GLU ASP GLN SEQRES 6 A 251 ILE THR LEU ILE GLN TYR SER TRP MET SER LEU SER SER SEQRES 7 A 251 PHE ALA LEU SER TRP ARG SER TYR LYS HIS THR ASN SER SEQRES 8 A 251 GLN PHE LEU TYR PHE ALA PRO ASP LEU VAL PHE ASN GLU SEQRES 9 A 251 GLU LYS MET HIS GLN SER ALA MET TYR GLU LEU CYS GLN SEQRES 10 A 251 GLY MET HIS GLN ILE SER LEU GLN PHE VAL ARG LEU GLN SEQRES 11 A 251 LEU THR PHE GLU GLU TYR THR ILE MET LYS VAL LEU LEU SEQRES 12 A 251 LEU LEU SER THR ILE PRO LYS ASP GLY LEU LYS SER GLN SEQRES 13 A 251 ALA ALA PHE GLU GLU MET ARG THR ASN TYR ILE LYS GLU SEQRES 14 A 251 LEU ARG LYS MET VAL THR LYS SER PRO ASN ASN SER GLY SEQRES 15 A 251 GLN SER TRP GLN ARG PHE TYR GLN LEU THR LYS LEU LEU SEQRES 16 A 251 ASP SER MET HIS ASP LEU VAL SER ASP LEU LEU GLU PHE SEQRES 17 A 251 CYS PHE TYR THR PHE ARG GLU SER HIS ALA LEU LYS VAL SEQRES 18 A 251 GLU PHE PRO ALA MET LEU VAL GLU ILE ILE SER ASP GLN SEQRES 19 A 251 LEU PRO LYS VAL GLU SER GLY ASN ALA LYS PRO LEU TYR SEQRES 20 A 251 PHE HIS ARG LYS SEQRES 1 B 15 PRO GLN ALA GLN GLN LYS SER LEU LEU GLN GLN LEU LEU SEQRES 2 B 15 THR GLU HET GOL A1984 6 HET DEX A1985 28 HETNAM GOL GLYCEROL HETNAM DEX DEXAMETHASONE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN DEX 9A-FLUORO-16BETA-METHYLPREDNISOLONE FORMUL 3 GOL C3 H8 O3 FORMUL 4 DEX C22 H29 F O5 FORMUL 5 HOH *101(H2 O) HELIX 1 1 PRO A 738 GLU A 746 1 9 HELIX 2 2 THR A 761 VAL A 786 1 26 HELIX 3 3 GLY A 789 LEU A 793 5 5 HELIX 4 4 PRO A 794 ASN A 823 1 30 HELIX 5 5 ASN A 836 SER A 843 1 8 HELIX 6 6 MET A 845 GLN A 863 1 19 HELIX 7 7 THR A 865 LEU A 878 1 14 HELIX 8 8 SER A 888 THR A 908 1 21 HELIX 9 9 GLY A 915 GLU A 948 1 34 HELIX 10 10 GLU A 948 LYS A 953 1 6 HELIX 11 11 PRO A 957 SER A 973 1 17 HELIX 12 12 SER B 1433 THR B 1440 1 8 SHEET 1 AA 2 LEU A 827 ALA A 830 0 SHEET 2 AA 2 LEU A 833 PHE A 835 -1 O LEU A 833 N ALA A 830 SHEET 1 AB 2 THR A 880 PRO A 882 0 SHEET 2 AB 2 ALA A 976 PRO A 978 -1 O LYS A 977 N ILE A 881 CISPEP 1 SER A 914 GLY A 915 0 -0.72 SITE 1 AC1 7 GLN A 825 PHE A 826 LEU A 827 GLU A 837 SITE 2 AC1 7 MET A 840 HIS A 853 HOH A2050 SITE 1 AC2 16 LEU A 766 LEU A 769 ASN A 770 ALA A 773 SITE 2 AC2 16 GLN A 776 SER A 810 ARG A 817 PHE A 829 SITE 3 AC2 16 MET A 845 MET A 852 PHE A 941 CYS A 942 SITE 4 AC2 16 THR A 945 VAL A 954 PHE A 956 HOH A2024 CRYST1 73.000 81.400 45.230 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013699 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012285 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022109 0.00000